None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Perimenopaual women aged 45 to 55 years 2) Kupperman Index(KI) score of 15 or higher 3) Who consented to participate inthis clinical tral and provided written informed consent prior to its commencement.
Exclusion criteria
Exclusion criteria: 1) Body mass index(BMI) esceeding 28 kg/m2 2) Use of hormone therapies such as female hormones or similar agents within the past 3 months 3) Current or past history of uterine, endometrial, breast, or sex hormone related cancers 4) History of hysterectomy or oophorectomy 5) Severe migraines within the past year, Diagnosis of thromboembolism, cerebrovascular disease, myocardial infarction, or unstable angina, or history of coronary angioplasty 6) Current use of antidepressants or other psychotropic medications 7) Unexplained uterine bleeding more than one year after menopause 8) Uncontrolled diabetes 9) Uncontrolled thyroid disorders 10) Substance or alcohol abusers 11) Inappropriate for the study as determined by the investigator 12) Use of thyroid hormones, clonidine, anticoagulants, or antithrombotic agents(e.g., warfarin, clopidogrel) within 3 months 13) Use of menopausal medications or health functional foods within 1 month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| functional health;blood;bone density;Assessment of adherence to study product intake | — |
Secondary
| Measure | Time frame |
|---|---|
| body measurements;nutritional assessment | — |
Countries
Korea, Republic of
Contacts
Kyung Hee University Global Campus